BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
We remain positive on diagnostic sector in India considering a growth potential of approximately 15% compound annual growth rate over medium term and possibility of multiple tailwinds that are likely to emerge in near to medium term.
These tailwinds include faster shift of unorganised business to organised players in current environment, potential consolidation in industry through inorganic or partnership model, upside from Covid-19 related reverse transcription-polymerase chain reaction (RT-PCR) as well as anti-body (or anti-gen) tests and sizeable scale which would help in mitigating any realisation-related potential risks.
The business for the companies have recovered at very fast pace after reaching a trough in Q1 FY21 and we expect normalization Q3 FY21 onwards.
We believe large organised players are best positioned to benefit from their scale and strong balance sheets.
Our recent interaction with company managements reinforces our view.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR